548 results on '"Grayson, Peter C."'
Search Results
152. Use of “Provisional” Designation for Response Criteria
153. Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis
154. 18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
155. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
156. Treatment of mucocutaneous manifestations in Behçet’s disease with anakinra: a pilot open-label study
157. A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity
158. Vasculitis Around the World: Epidemiologic Insights into Causality and a Need for Global Partnerships
159. Abnormal molecular response to Takayasu arteritis causing extensive large-vessel calcification
160. Infections and the risk of incident giant cell arteritis: a population-based, case-control study
161. Defining the Nasal Transcriptome in Granulomatosis with Polyangiitis
162. Clinical Manifestations Are Evolving and Progressive in Patients with Vexas Syndrome
163. Review: Neutrophils as Invigorated Targets in Rheumatic Diseases
164. A small n sequential multiple assignment randomized trial design for use in rare disease research
165. Clinical Images: Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient
166. At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases
167. Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.
168. 18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis.
169. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2
170. Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study.
171. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS
172. Hyperuricemia and Incident Hypertension: A Systematic Review and Meta-Analysis
173. What matters for patients with vasculitis?
174. Lumpers and Splitters: Ongoing Issues in the Classification of Large Vessel Vasculitis
175. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis
176. Eosinophilia in Vexas Syndrome: Expanding Hematologic Phenotype
177. Clonal Hematopoiesis in a Broad Age Spectrum of Systemic Vasculitis
178. Clonal Hematopoiesis in Vexas Syndrome
179. Thrombotic Manifestations in Patients with Vexas Syndrome
180. DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways
181. DNMT3A/TET2Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1and MPLOncogenic Pathways
182. Infections and the risk of incident giant cell arteritis: a population-based, case-control study.
183. Causal Attributions about Disease Onset and Relapse in Patients with Systemic Vasculitis
184. Musculoskeletal Ultrasound Objective Structured Clinical Examination: An Assessment of the Test
185. Illness Perceptions and Fatigue in Systemic Vasculitis
186. Raynaud's Phenomenon
187. Digital Ischemia in Systemic Sclerosis
188. Polyarteritis Nodosa
189. Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome
190. Spectrum of clonal hematopoiesis in VEXAS syndrome
191. Advanced Molecular Imaging in Large-Vessel Vasculitis: Adopting FDG-PET into a Clinical Workflow
192. Antineutrophil Cytoplasmic Antibodies, Autoimmune Neutropenia, and Vasculitis
193. Hyperuricemia and incident hypertension: A systematic review and meta-analysis
194. Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease.
195. Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
196. At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases
197. Musculoskeletal Ultrasound Objective Structured Clinical Examination: An Assessment of the Test.
198. New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis.
199. Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis.
200. Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.